FDA 483 vs. Warning Letter: 8 Questions for Food and Supplement Teams


Your team received a Form FDA 483. Or maybe a Warning Letter arrived in the mail. The terms sound similar, but they are different documents, and the next steps depend on what you actually received.

Here are eight questions to settle before drafting a reply. Keep the correspondence open while you read. The instructions in your own file matter more than a deadline or example copied from another company.

Food quality and operations managers review inspection correspondence and response dates together
Confirm the document, deadline, and response instructions before drafting.

This article is general information for food and dietary supplement businesses. It is not legal or regulatory advice. Requirements vary by product, process, facility, and FDA program. Get qualified advice when you need a legal or technical determination.

For an evidence-first response approach, read FDA 483 Response: Use AI to Organize Your Evidence Before You Reply. The FDA Warning Letter Response Prompts book includes prompts to adapt to your approved review process.

1. Is a Form FDA 483 the same as a Warning Letter?

No. FDA issues a Form 483 at the close of an inspection when the investigator has observed conditions that, in the investigator’s judgment, may indicate violations. A Warning Letter is a separate communication that tells a firm FDA believes there are significant violations and requests a response within a stated timeframe.

That difference matters. Put the exact document in the response file, record its date, and follow its instructions. A web article about a 483 will not tell you how to answer a Warning Letter addressed to your company.

2. Does a Form 483 mean FDA made a final decision?

FDA says a Form 483 is not a final agency determination. The agency considers the observations with the Establishment Inspection Report, evidence gathered during the inspection or through other activity, and the company’s response.

That does not make the observations unimportant. FDA says its investigators are instructed to note conditions they observed, and the form is not meant to list every possible issue at the facility. Your quality team should assess the observations and any related conditions through its own process.

3. Do we have to respond in writing?

FDA encourages companies to respond in writing to Form 483 observations with corrective action information. For food safety inspections, FDA highly recommends written responses to both the observations listed on the form and verbal points discussed during the close-out meeting.

A Warning Letter asks for a response and specifies what the firm should send and when. Read that letter line by line. If instructions are unclear, ask the appropriate contact or get advice from your regulatory or legal team.

4. Is the response deadline always 15 working days?

Do not assume that one deadline fits every document or program. FDA’s food inspection guidance describes a request for a written response within 15 working days of the inspection close. A Warning Letter sets out its own response period. Other products and inspection programs may use different instructions.

Write down the date the clock starts, how the days are counted, where the response goes, and how it should be submitted. Have a second person verify that against the original correspondence. If a deadline seems unclear or hard to meet, escalate the question promptly.

5. What if we disagree with an observation?

FDA’s Warning Letter overview says the recipient has an opportunity to provide its reasoning and supporting information if it disagrees with FDA’s concerns. A response should stay factual and specific. Point to the records or other evidence that support the firm’s position.

Do not ignore the observation or write a broad denial with no supporting material. Have qualified reviewers assess the issue before making legal or technical claims. The response can explain a disagreement while also making clear what the facility is doing to evaluate or address any condition it independently identified.

6. Do dietary supplement facilities follow the same rules as food facilities?

Not in every respect. FDA explains that facilities dealing with dietary supplements may be subject to 21 CFR Part 111. FDA also says Part 117 subparts C and G generally do not apply to dietary supplement manufacturing, processing, packaging, or holding when the facility complies with Part 111 and the applicable serious adverse event reporting provision. Other Part 117 provisions may still apply.

Dietary ingredients and mixed operations can change the analysis. Do not assume an ingredient supplier, co-manufacturer, labeler, warehouse, or conventional food line has the same status as a supplement-only operation. Confirm the product and activity, then check the applicable FDA materials.

7. What records belong in the response?

Choose records that support the exact statements in the response. Depending on the observation and work completed, those might include approved procedures, training records, maintenance records, monitoring logs, product traceability, evaluation or disposition records, photographs, or a revised food safety plan.

FDA’s foreign food facility Q&A describes supporting materials such as repair records, new monitoring activities, pictures, and revised HACCP plans. That is an example of evidence types, not a mandatory attachment list for every firm. Use the instructions for your own inspection, and make each exhibit easy to find from the response text.

If the response says…Check for evidence such as…Do not claim…
A procedure changedApproved version and revision historyThat it is in use if it is still a draft
Staff received trainingTraining material, date, and attendance recordThat every relevant shift attended without checking the roster
Product was evaluatedTraceability, safety assessment, and disposition records as applicableThat all product was covered if the review was limited
A corrective action is effectiveDefined review method and documented resultThat recurrence is impossible

8. Can AI draft or review the reply?

AI can help organize a record list, compare dates, flag missing attachment references, or make approved text easier to scan. It cannot verify a production record, decide whether a batch is safe, establish root cause, or tell you what FDA will accept.

Try a narrow review prompt with information your company has approved for the tool:

“Compare this response draft with the evidence index. Flag any claim without a cited source, conflicting date, unclear status, or statement that goes beyond the record. Do not make a legal or regulatory conclusion, invent facts, or rewrite the response. Return each issue as a question for a qualified reviewer. Draft and index: [approved, de-identified text].”

Check every flag against the original record. Remove client, employee, supplier, and product details unless your policy permits sharing them. Keep the AI result out of the official evidence file unless your approved procedure says otherwise.

Quick decision table

You received…Start by checking…
Form FDA 483Close-out notes, response instructions, deadline, observation list, and relevant records.
Warning LetterEach cited concern, the specific response timeframe, recipient, submission method, and requested information.
Both documents at different timesWhether the later letter changes or adds instructions, and how the response file should be organized.
Questions about supplement or food rule coverageProduct identity, operation performed, applicable exemptions, and current FDA requirements.

If you are unsure what a document requires, pause the draft and get a qualified reviewer involved. It is easier to correct the plan before the response is sent.

Who should review the response?

Pick reviewers based on the issue. Quality should check the controlled records and status. Production or sanitation leads should confirm that the described process change matches what happened on the floor. Regulatory staff should verify how the response fits the applicable program and correspondence. Legal counsel may need to review disputed findings, product safety questions, or enforcement concerns.

One person should own the final version and attachment index. Everyone else should review the same controlled copy. If a reviewer suggests a change, check whether the evidence supports it before accepting the edit. Keep a short approval record so the team knows which version was authorized to send.

What should we do after we send it?

Save the exact response and attachments, the sent message or portal receipt, and any confirmation you receive. Continue tracking open actions in the facility’s normal quality system. If FDA asks for more information, add that request and response to the same controlled file.

Do not treat silence as approval or assume the matter is closed because a response was sent. FDA says it reviews the 483, the Establishment Inspection Report, other evidence, and the firm’s response before deciding what further action, if any, is appropriate. Keep making the changes your own assessment and applicable requirements call for.

Keep your reply tied to the file

Before submission, check that every response statement has a source, every planned action has an owner, and every completed action has evidence. Keep the deadline and delivery instructions beside the correspondence, not in someone’s memory.

Read the FDA Form 483 FAQ, food inspection guidance, and the FDA overview of Warning and Close-Out Letters. The FSMA FAQs address the relationship between dietary supplement and human food requirements.

Continue with the response pillar, six response gaps to catch, the seven-step workflow, and the evidence and follow-up templates. For prompts you can adapt, see the FDA Warning Letter Response Prompts book.

Frequently asked questions

Is an FDA 483 the same as a Warning Letter?

No. A Form 483 records inspectional observations. A Warning Letter is a separate agency communication that describes FDA’s concerns and requests a response under its own instructions.

Does an FDA 483 prove a violation?

FDA says the form is not a final agency determination. It is considered with other inspection evidence and the firm’s response.

Is the response deadline always 15 working days?

FDA food inspection guidance describes a written response request within 15 working days of inspection close. Check the specific instructions and deadline provided to your facility.

Do dietary supplement manufacturers follow Part 117?

FDA says Part 117 subparts C and G generally do not apply to supplement operations that comply with Part 111 and the applicable serious adverse event reporting provision. Other requirements may apply.

Can AI decide how we should answer FDA?

No. AI can help organize approved records or flag missing details. Qualified staff decide the facts, response, and corrective actions.

Leave a Comment

Item added to cart.
0 items - $0.00